Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
New budgeting challenges require flexible thinking. This brief guide offers strategies to adjust your plan while maintaining financial stability.
24,577 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Could SpaceX expand from rockets to handheld devices? This article examines the idea of spacex planning make smartpho...
Oklo stock has faced big swings, but analysts see a potential upside. This guide breaks down what the projection to $...
Ultra-prime Manhattan sales are accelerating even as policy debates intensify. Brokers say buyers and sellers remain ...
A prominent hedge fund reduced its Wix stake by 25,000 shares in late 2025. This article breaks down what dorsal capi...
Institutional activity in Bitcoin ETFs is more nuanced than daily inflows suggest. This piece examines how market mak...
Sweetgreen faces a turning point after a tough year. This article examines if a 'wraps' strategy—bundled menu changes...
The Department of Justice has released additional Epstein-related records that include unverified accusations about P...
Greg Abel has stepped into Berkshire Hathaway’s top role with a plan that blends steady operations with a measured ap...
A new wave of investors is changing how rental markets work. Out-of-town buyers are driving rental demand in many top...
In a tightening insurance landscape, resilience upgrades are becoming the default. This report examines how builders ...
Bitcoin surges in early trading after news that Iran postponed strikes. The move highlights how geopolitical headline...